Regenicin, Inc.: 10-Q filed 2013-05-20
What Regenicin, Inc. reported in its quarterly report filed 2013-05-20 (fiscal Q2 2013): 19 published measures, 51 facts as tagged in accession 0001255294-13-000388.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-05-20
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001255294-13-000388 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Regenicin, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 3,056,687 | USD | |
| At 2012-09-30 | 3,095,913 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 3,647,788 | USD | |
| At 2012-09-30 | 3,550,395 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -591,101 | USD | |
| At 2012-09-30 | -454,482 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | -252,670 | USD | 182 |
| 2007-09-06 to 2013-03-31 | -3,491,268 | USD | 2034 |
| 2011-10-01 to 2012-03-31 | -619,987 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | 243,083 | USD | 182 |
| 2007-09-06 to 2013-03-31 | 6,523,255 | USD | 2034 |
| 2011-10-01 to 2012-03-31 | 651,834 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2007-09-06 to 2013-03-31 | -3,007,500 | USD | 2034 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -9,031,105 | USD | |
| At 2012-09-30 | -8,187,901 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2007-09-06 to 2013-03-31 | 1,248,637 | USD | 2034 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -176,613 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -483,839 | USD | 182 |
| 2007-09-06 to 2013-03-31 | -7,621,040 | USD | 2034 |
| 2012-01-01 to 2012-03-31 | -821,307 | USD | 91 |
| 2011-10-01 to 2012-03-31 | -1,630,844 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 49,187 | USD | |
| At 2012-09-30 | 88,413 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 3,582,127 | USD | |
| At 2012-09-30 | 3,550,395 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,680,385 | USD | |
| At 2012-09-30 | 1,655,052 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 176,613 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 483,839 | USD | 182 |
| 2007-09-06 to 2013-03-31 | 7,621,040 | USD | 2034 |
| 2012-01-01 to 2012-03-31 | 821,307 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 1,630,844 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2007-09-06 to 2013-03-31 | 1,483,719 | USD | 2034 |
| 2012-01-01 to 2012-03-31 | 449,377 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 869,859 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 103,124,964 | shares | |
| At 2012-09-30 | 89,407,964 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 8,171,870 | USD | |
| At 2012-09-30 | 7,274,799 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 24,700 | USD | |
| At 2012-09-30 | 54,339 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -283,553 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -843,204 | USD | 182 |
| 2007-09-06 to 2013-03-31 | -9,031,105 | USD | 2034 |
| 2012-01-01 to 2012-03-31 | -1,055,778 | USD | 91 |
| 2011-10-01 to 2012-03-31 | -1,870,784 | USD | 183 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 176,613 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 483,839 | USD | 182 |
| 2007-09-06 to 2013-03-31 | 4,888,684 | USD | 2034 |
| 2012-01-01 to 2012-03-31 | 371,930 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 760,985 | USD | 183 |
Inspect the source
- Entity
- Regenicin, Inc. / CIK 0001412659
- Captured
- SEC response SHA-256
66d33e554adc1e643294d5e778c52aa5121a74d07c71bf640453c952267c0d14
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001412659.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))